| Tanya Fuller-pellin, FNP | |
|
220 Keowee Trl, Clemson, SC 29631-1448 | |
| (864) 653-4071 | |
| Not Available |
| Full Name | Tanya Fuller-pellin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 220 Keowee Trl, Clemson, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639544240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 19819 (South Carolina) | Primary |
| Entity Name | Internal Medicine & Cardiology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275561813 PECOS PAC ID: 9638135999 Enrollment ID: O20041208000415 |
News Archive
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
Last evening at the U.S. Business Leadership Network's (USBLN) Annual Conference and National Career Fair, several leading disability organizations launched the Campaign for Disability Employment, a new collaborative effort to promote positive employment outcomes for people with disabilities.
A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.
BioNeutral Group Inc., a specialty chemical technology-based life science company, today announced financial results for the third quarter and nine-month period ended July 31, 2010.
There are many faces of stroke. This year, 700,000 Americans of all ages, genders and ethnicities will have a new or recurrent stroke.
› Verified 5 days ago
| Entity Name | Baptist Easley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144452889 PECOS PAC ID: 0840337606 Enrollment ID: O20091027000684 |
News Archive
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
Last evening at the U.S. Business Leadership Network's (USBLN) Annual Conference and National Career Fair, several leading disability organizations launched the Campaign for Disability Employment, a new collaborative effort to promote positive employment outcomes for people with disabilities.
A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.
BioNeutral Group Inc., a specialty chemical technology-based life science company, today announced financial results for the third quarter and nine-month period ended July 31, 2010.
There are many faces of stroke. This year, 700,000 Americans of all ages, genders and ethnicities will have a new or recurrent stroke.
› Verified 5 days ago
| Entity Name | Providence House Calls Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689912495 PECOS PAC ID: 1759528250 Enrollment ID: O20130430000366 |
News Archive
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
Last evening at the U.S. Business Leadership Network's (USBLN) Annual Conference and National Career Fair, several leading disability organizations launched the Campaign for Disability Employment, a new collaborative effort to promote positive employment outcomes for people with disabilities.
A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.
BioNeutral Group Inc., a specialty chemical technology-based life science company, today announced financial results for the third quarter and nine-month period ended July 31, 2010.
There are many faces of stroke. This year, 700,000 Americans of all ages, genders and ethnicities will have a new or recurrent stroke.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tanya Fuller-pellin, FNP 14 Blue Slate Ct, Greenville, SC 29607-5077 Ph: (864) 992-6902 | Tanya Fuller-pellin, FNP 220 Keowee Trl, Clemson, SC 29631-1448 Ph: (864) 653-4071 |
News Archive
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
Last evening at the U.S. Business Leadership Network's (USBLN) Annual Conference and National Career Fair, several leading disability organizations launched the Campaign for Disability Employment, a new collaborative effort to promote positive employment outcomes for people with disabilities.
A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.
BioNeutral Group Inc., a specialty chemical technology-based life science company, today announced financial results for the third quarter and nine-month period ended July 31, 2010.
There are many faces of stroke. This year, 700,000 Americans of all ages, genders and ethnicities will have a new or recurrent stroke.
› Verified 5 days ago
Ruth Anne Etter, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1300 Tiger Blvd, Clemson, SC 29631 Phone: 866-389-2727 | |
Mrs. Pamela Carraway Hitt, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1300 Tiger Blvd, Clemson, SC 29631 Phone: 864-653-6724 | |
Dr. Rosanne Harkey Pruitt, PHD, APRN,BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Sullivan Ctr, 106 Edwards Hall, Clemson, SC 29634 Phone: 864-656-5528 Fax: 864-656-5488 | |
Paula J Watt, PHD, APRN-BC, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 101 Edwards Hall, Clemson, SC 29634 Phone: 864-656-3076 Fax: 864-656-7694 | |
Brandi Leigh Harper, DNP, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1300 Tiger Blvd, Clemson, SC 29631 Phone: 864-653-6724 | |
Pattie B Burriss, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 885 Tiger Blvd, Clemson, SC 29631 Phone: 864-654-6800 | |
Hilary Koster, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 101 Chapman Hill Rd, Clemson, SC 29631 Phone: 864-455-6900 Fax: 864-455-6469 |